|
Sign In to gain access to subscriptions and/or personal tools.
|
Commonly asked questions: hypertension
John R Petrie
Division of Cardiovascular and Medical Sciences, Glasgow Royal Infirmary, University of Glasgow, UK, j.r.petrie{at}clinmed.gla.ac.uk
Mike Kirby
The Surgery, Nevells Road, Letchworth, UK
References
- Brown MJ, Cruickshank JK, Dominiczak AF et al. Better blood pressure control: how to combine drugs. J Hum Hypertens 2003;17:81-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Curb JD, Pressel SL, Cutler JA et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-92.[Abstract/Free Full Text]
- Staessen JA, Fagard R., Thijs L. et al. Randomised, double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-62.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dahlof B., Devereux RB, Kjeldsen SE et al. The Losartan Intervention For Endpoint Reduction in Hypertension Study. Lancet 2002;359:995-1003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Heart Protection Study Collaborative Group. MRC/ BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes. Lancet 2003;361:2005-16.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lindholm LH Major benefits from cholesterol-lowering in patients with diabetes. Lancet 2003;361:2000-01.[Medline]
[Order article via Infotrieve]
- Stevens R., Kothari V., Adler AI, Stratton IM, Holman RR UKPDS 56: The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes. Clin Sci 2001;101:671-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ramsay LE, Williams B., Johnston GD et al. Guidelines for the management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999;13:569-92.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. New Engl J Med 2001;344:3-10.[Abstract/Free Full Text]
- MRC Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-104.[Abstract/Free Full Text]
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.[Abstract/Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 4,
270-273 (2003)
DOI: 10.1177/14746514030030040601

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|